Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Lung Diseases(Electronic Edition) ›› 2024, Vol. 17 ›› Issue (02): 189-194. doi: 10.3877/cma.j.issn.1674-6902.2024.02.004

• Original Article • Previous Articles    

Differential expression of CXCR5 molecule in pulmonary tuberculosis and pulmonary sarcoidosis-associated granulomatous tissues

Min Sha1, Qiuxia Qu2, Weidong Zhu3, Cheng Chen1,()   

  1. 1. Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, 215000, China
    2. Laboratory of Clinical Immunology, The First Affiliated Hospital of Soochow University, Suzhou 215000, China
    3. Department of Pathology, The First Affiliated Hospital of Soochow University, Suzhou 215000, China
  • Received:2023-10-17 Online:2024-04-25 Published:2024-06-12
  • Contact: Cheng Chen

Abstract:

Objective

To analyze CXCR5 molecule expression in different pulmonary granulomatous tissues and to explore its differential diagnostic value between pulmonary tuberculosis and pulmonary sarcoidosis.

Methods

43 patients with lung granulomatosis were diagnosed by bronchoscopic lung tissue biopsy from the First Affiliated Hospital of Soochow University from January 2016 to December 2022. Fifteen cases of pulmonary sarcoidosis and 28 cases of pulmonary tuberculosis were comprehensively diagnosed. The expression of CXCR5 molecules in tissue sections was analyzed by immunohistochemistry. The expression of CXCR5 in CD8+ T cells and CD4+ T cells of granuloma tissue sections was analyzed by dual immunofluorescence labeling, and quantitative scoring was performed.

Results

In pulmonary tuberculosis granuloma tissues, there were 22 cases (78.57%) with positive expression of CXCR5 greater than 2 points, 12 cases (42.86%) with expression intensity greater than 2 points, 10 cases (35.71%) with quantitative scores less than 3 points, and 8 cases (28.57%) with quantitative scores greater than 6 points. In the granuloma tissues of pulmonary sarcoidosis, there were 9 cases (60.00%) with positive expression of CXCR5 greater than 2 points, and the intensity of CXCR5 expression was less than 2 points in 15 cases(100.00%), and 11 cases (73.33%) were less than 3 points. Compared with pulmonary sarcoidosis, the expression intensity of CXCR5 molecules in pulmonary tuberculous granulomatous tissues was increased. The overall score of CXCR5 molecular expression was also increased (4.00±2.12) vs.( 2.18±1.87) (P<0.05). According to the ROC analysis, CXCR5 expression quantitative score was the best cut-off value when it was equal to 2.85 points. The AUC of the differential diagnosis of pulmonary tuberculosis and pulmonary sarcoidosis was 0.733, with a specificity of 73.3% and a sensitivity of 64.3%. Fluorescence colocalization analysis showed that the infiltration levels of follicular CD4+ T cells (0.7933 vs. 0.5150) and follicular CD8+ T cells (0.8350 vs. 0.6100) in pulmonary tuberculosis granuloma tissues were also increased compared with pulmonary sarcoidosis(P<0.05).

Conclusion

There are differences in the expression of CXCR5 molecule and surface-labeled follicular CD4+ T cells and follicular CD8+ T cells in granulomatous tissues of pulmonary tuberculosis and pulmonary sarcoidosis, which has differential diagnostic value.

Key words: Pulmonary sarcoidosis, Pulmonary tuberculosis, Granulomatous diseases, CXCR5, T cells

京ICP 备07035254号-28
Copyright © Chinese Journal of Lung Diseases(Electronic Edition), All Rights Reserved.
Tel: 023-65425691 E-mail: xqcjld@163.com
Powered by Beijing Magtech Co. Ltd